Elective implantation of intracoronary stents without intravascular ultrasound guidance or subsequent warfarin

Catheterization and Cardiovascular Diagnosis

Volumn 37, Issue 4, 1996, Pages 355-359

  Sankardas, Mullasari Ajit ^a   McEniery, Paul Timothy ^a   Aroney, Constantine Nicholas ^a   Bett, John Hugh Nicholas ^a  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

Aspirin; Intravascular ultrasound; Stents

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE; WARFARIN;

ADULT; AGED; ANGIOGRAPHY; ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; DIARRHEA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; RASH; REVASCULARIZATION; STENT; THROMBUS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ASPIRIN; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY THROMBOSIS; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREMEDICATION; RECURRENCE; STENTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; WARFARIN;

EID: 0029939783     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199604)37:4<355::AID-CCD1>3.0.CO;2-A     Document Type: Article

References (34)

1. Holmes DR Jr, Vlietstra RE, Smith HC, et al: Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA Registry of the National Heart, Lung and Blood Institute. Am J Cardiol 53:77C-81C, 1984.
2. Grüntzig AR, King SB III, Schlumpf M, Seingenthaler W: Long-term follow-up after percutaneous transluminal coronary angioplasty: The early Zurich experience. N Engl J Med 316:1127-32, 1987.
3. Nobuyoshi M, Kimura T, Nosaka H, et al: Restenosis after successful percutaneous coronary angioplasty: Serial angiographic follow-up of 229 patients. J Am Coll Cardiol 12:616-623, 1988.
4. Fischman DL, Leon MB, Baim DS, et al: for the Stent Restenosis Study Investigators. A randomised comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496-501, 1994.
5. Serruys PW, de Jaegere P, Kiemeneij F, et al, for the BENESTENT Study Group: A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489-495, 1994.
6. Goldberg SL, Colombo A, Nakamura S, Alamgor Y, Maiello L, Tobis JM: Benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents. J Am Coll Cardiol 24:996-1003, 1994.
7. Colombo A, Nakamura S, Hall P, et al: A prospective study of Gianturco-Roubin coronary stent implantation without anticoagulation. J Am Coll Cardiol 25:50A, 1995.
8. Blasani R, Mudra H, Schülen H, et al: Intravascular ultrasound guided optimized emergency coronary Palmaz-Schatz stent placement without post procedural systemic anticoagulation. J Am Coll Cardiol 25:197A, 1995.
9. Russo RJ, Schatz RA, Sklar M, et al: Ultrasound guided coronary stent implantation without prolonged systemic anticoagulation. J Am Coll Cardiol 25:50A, 1995.
10. Colombo A, Nakamura S, Hall P, et al: A prospective study of Wiktor coronary stent implantation without anticoagulation. J Am Coll Cardiol 25:239A, 1995.
11. Colombo A, Hall P, Nakamura S, et al: Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 91:1676-1688, 1995.
12. Biengino S, Nakamura S, Hall P, et al: A cost analysis of intravascular ultrasound guided coronary stenting without anticoagulation vs. the traditional method of stenting with anticoagulation. J Am Coll Cardiol 25:197A, 1995.
13. Gaglione A, Tiecco F, Maeillo L, Nakamura S, Martini G, Colombo A: High pressure assisted intracoronary stent implantation without subsequent anticoagulation. Circulation 90:I-622, 1994.
14. Schülen H, Blasani R, Mudra H, et al: Stenting for progressive dissection during PTCA: Clinical, angiographic and intravascular ultrasound criteria to define a low-risk group not requiring subsequent anticoagulation. J Am Coll Cardiol 25:123A, 1995.
15. Barragan P, Silvestri M, Sainsous J, et al: Prevention of subacute occlusion after coronary stenting with ticlopidine regimen without intravascular ultrasound guided stenting. J Am Coll Cardiol 25: 182A, 1995.
16. Lablanche J-M, Grollier G, Danchin N, et al: Full antiplatelet therapy without anticoagulation after coronary stenting. J Am Coll Cardiol 25:181A, 1995.
17. Van Belle E, McFadden EP, Bauters C, et al: Combined antiplatelet therapy without anticoagulation: An effective alternative to prevent subacute thrombosis after coronary stenting? A 3 month follow-up. J Am Coll Cardiol 25:197A, 1995.
18. Fajadet J, Jordan C, Carvalho H, et al: Percutaneous trans radial coronary stenting without coumadin can reduce vascular access complications and hospital stay. J Am Coll Cardiol 25:182A, 1995.
19. Myler RK, Shaw RE, Stertzer SH, et al: Lesion morphology and coronary angioplasty: Current experience and analysis. J Am Coll Cardiol 19:1641-1652, 1992.
20. Guidelines for percutaneous transluminal coronary angioplasty (chairman - Ryan TJ). J Am Coll Cardiol 12:529-545, 1988.
21. Black AJR, Namay DL, Niederman AL, Lembo NJ, Roubin GS, Douglas JS Jr, King SB III: Tear or dissection after coronary angioplasty: Morphological correlates of an ischemic complication. Circulation 79:1035-1042, 1989.
22. Schatz RA, Baim DS, Leon M, et al: Clinical experience with the Palmaz-Schatz coronary stent. Circulation 83:148-161, 1991.
23. Shaknovich A, Rocha-Singh K, Tierstein P, et al: Subacute stent thrombosis in Palmaz-Schatz stents in native coronary arteries. Time course, acute management and outcome. US multicenter experience. Circulation 86:I-442, 1992.
24. Hermann HC, Hirshfield JW, Buchbinder M, et al: Emergent coronary stenting for failed percutaneous transluminal coronary angioplasty. Circulation 84:II-590, 1991.
25. Kiemeneij F, Laarman G, van der Wicken R, et al: Emergency coronary stenting with the Palmaz-Schatz stent for failed percutaneous coronary angioplasty: Results of a learning phase. Am Heart J 126:23-31, 1993.
26. Doucet S, Fajadet J, Gaillard J, et al: Predictors of thrombotic occlusion following coronary Palmaz-Schatz stent implantation. Circulation 86:I-114, 1992.
27. Hande M, Erbel R, Issa H, Straub U, Rupprecht HJ, Treese N, Meyer J: Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J 126:15-22, 1993.
28. Barragan P, Sainsous J, Silvestri M, Bouvier JL, Comet B, Siméoni JB, Charmasson C, Bremondy M: Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn 32:133-138, 1994.
29. Mudra H, Klauss V, Blasini R, Kroetz M, Rieber J, Regar E, Theisen K: Ultrasound guidance of Palmaz-Schatz intracoronary stenting with a combined intravascular ultrasound balloon catheter. Circulation 90:1252-1261, 1994.
30. Blengino S, Maiello L, Hall P, Nakamura S, Martini G, Colombo A: Randomised trial of coronary stent implantation without anticoagulation: Aspirin vs Ticlopidine. Circulation 90:I-124, 1994.
31. Morice M-C, Bourdonnec C, Lefevre T, Blanchard D, Monassier J-P, Lienhart Y, Commeau P, Makowski S, Labrunie P, Cribier A, Joly P: Coronary stenting without Coumadin. Phase III. Circulation 90:I-125, 1994.
32. Gallerani M, Manfredini R, Morratelli S: Non-hæmorrhagic adverse reactions of oral anticoagulant therapy. Int J Cardiol 49: 1-7, 1994.
33. Hass WK, Easton JD, Adams HP, et al: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 321:501-507, 1989.
34. Gent M, Blakely JA, Easton JD, et al: The Canadian American ticlopidine study (CATS) in thromboembolic stroke. Lancet 1:1215-1220, 1989.